LPWM
IRWD icon

Lake Point Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Lake Point Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-735
Closed -$9K – 472
2022
Q1 		$9K Hold
735
– – ﹤0.01% 178
2021
Q4 		$9K Hold
735
– – ﹤0.01% 188
2021
Q3 		$10K Hold
735
– – ﹤0.01% 164
2021
Q2 		$9K Buy
+735
New +$8.41K ﹤0.01% 185

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Lake Point Wealth Management's IRWD Position: Q2 2022 in Review

Lake Point Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 735 shares — an estimated $9K sold.

Lake Point Wealth Management first reported a position in IRWD in Q2 2021 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Lake Point Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Lake Point Wealth Management sold 735 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $9K.
  • Lake Point Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Lake Point Wealth Management's Ironwood Pharmaceuticals position peaked at $10K in Q3 2021.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.